← Amphastar Pharmaceuticals, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | $10.5m |
$4.5m
-57.20%
|
($5.7m)
-227.28%
|
$48.9m
+952.89%
|
$1.4m
-97.13%
|
$62.1m
+4327.37%
|
$91.4m
+47.12%
|
$137.5m
+50.51%
|
$159.5m
+15.98%
|
$98.1m
-38.51%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | ($6.7m) | $46.5m | $1.1m | $63.3m | $91.4m | $137.5m | $159.5m | $98.1m | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | ($922k) | ($2.4m) | ($306k) | $1.2m | — | — | — | — | — | |
| Depreciation, Depletion and Amortization | $12.0m | $12.6m | $14.5m | $7.1m | $9.0m | $10.2m | $12.6m | $25.7m | $28.2m | $31.6m | $64.7m | |
| Depreciation | $12.0m | $12.6m | $14.5m | $17.1m | $20.5m | $22.2m | $23.8m | $25.2m | $28.2m | $31.6m | $39.6m | |
| Amortization of Debt Issuance Costs | — | — | — | — | — | $219k | $466k | $11.4m | $6.0m | $3.4m | — | |
| Amortization of Intangible Assets | $2.5m | $2.9m | $2.0m | $1.0m | $1.0m | $1.3m | $1.4m | $12.8m | $24.7m | $25.0m | — | |
| Capitalized Computer Software, Amortization | — | — | — | — | — | — | — | — | — | $0 | — | |
| Deferred Income Tax Expense (Benefit) | ($4.0m) | $2.7m | ($4.4m) | $7.5m | $917k | $3.7m | ($15.9m) | ($13.9m) | ($17.1m) | $28.7m | $27.6m | |
| Share-based Payment Arrangement, Noncash Expense | $15.1m | $17.1m | $16.7m | $17.3m | $20.5m | $18.7m | $17.9m | $20.2m | $24.4m | $27.3m | $28.9m | |
| Share-based Payment Arrangement, Expense | $15.1m | $17.1m | $16.7m | $17.3m | $20.5m | $18.7m | $17.9m | $20.2m | $24.4m | $27.3m | $28.9m | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | ($208k) | ($1.2m) | ($2.0m) | ($573k) | — | — | |
| Nonoperating Income (Expense) | ($746k) | $2.5m | ($1.3m) | $60.3m | ($6.3m) | $14.3m | $8.5m | ($25.6m) | ($15.7m) | ($16.8m) | — | |
| Other Nonoperating Income (Expense) | $8k | $2.9m | ($1.5m) | $59.4m | ($6.6m) | $14.5m | $9.1m | ($3.9m) | $4.1m | $23k | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | ($6.4m) | $8.1m | $16.3m | ($6.7m) | $20.2m | $14.9m | $10.1m | $26.1m | $21.7m | $6.4m | ($12.1m) | |
| Increase (Decrease) in Inventories | $9.7m | ($18.6m) | $6.0m | $41.1m | ($15.3m) | ($1.3m) | $11.7m | $1.7m | $48.8m | $21.1m | $11.2m | |
| Inventory Write-down | — | $8.5m | $12.9m | $9.4m | $13.9m | $24.6m | $17.2m | $18.8m | $14.0m | $6.0m | — | |
| Net Cash Provided by (Used in) Operating Activities | $38.6m |
$39.2m
+1.68%
|
$38.2m
-2.60%
|
$41.8m
+9.35%
|
$57.3m
+37.12%
|
$98.0m
+71.12%
|
$89.2m
-8.99%
|
$183.5m
+105.76%
|
$213.4m
+16.28%
|
$156.1m
-26.84%
|
$184.6m
+18.25%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $21.4m | $35.1m | $46.8m | $41.6m | $33.9m | $27.5m | $24.0m | $38.2m | $41.0m | $34.9m | ($31.7m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | ($1.2m) | $2.3m | ($1.4m) | $17.1m | $20.5m | $22.2m | $23.8m | $25.2m | $28.2m | $31.6m | ($519k) | |
| Restricted Cash and Investments, Current | — | $4.2m | $4.2m | — | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Investing Activities | ($39.5m) | ($38.8m) | ($42.2m) | ($50.5m) | ($36.4m) | ($28.7m) | ($32.8m) | ($649.1m) | ($124.9m) | ($70.3m) | ($52.1m) | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | $14.7m | $9.7m | $5.7m | $6.4m | $8.4m | $36.7m | $1.8m | $318.7m | $8.3m | $223k | ($702k) | |
| Proceeds from Issuance of Long-term Debt | $10.2m | $19.0m | $8.4m | $3.6m | $6.3m | $70.0m | — | $845.0m | — | — | $445k | |
| Payments for Repurchase of Common Stock | $9.9m | $30.7m | $25.0m | $22.3m | $24.4m | $28.9m | $39.9m | $58.1m | $85.5m | $75.6m | — | |
| Net Cash Provided by (Used in) Financing Activities | $7.1m |
($7.7m)
-208.10%
|
$25.0m
+424.02%
|
($3.8m)
-115.13%
|
($2.2m)
+40.63%
|
($37.0m)
-1548.17%
|
($26.4m)
+28.58%
|
$454.1m
+1817.51%
|
($81.0m)
-117.83%
|
($67.4m)
+16.71%
|
($96.5m)
-43.07%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | ($4.9m) | $20.7m | ($12.7m) | $19.0m | $32.1m | $29.7m | ($11.8m) | $7.3m | $18.6m | $224.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | ($4.9m) | $88.2m | $75.5m | $94.5m | $126.6m | $156.3m | $144.5m | $151.8m | $170.4m | $224.0m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $81k | $504k | ($274k) | ($104k) | $352k | ($223k) | ($220k) | ($282k) | ($190k) | $210k | ($172k) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $20.3m | $19.1m | $11.8m | $7.8m | $24.4m | $16.8m | $19.2m | $14.2m | $12.2m | $6.4m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $1.7m | $1.9m | $2.4m | $2.4m | $2.2m | $2.1m | $3.0m | $17.6m | $26.8m | $23.2m | — | |
| Income Taxes Paid, Net | $3.4m | $4.9m | $339k | $5.7m | $3.4m | $8.1m | $44.4m | $49.0m | $40.1m | $22.7m | — | |
| Additional Financial Items | ||||||||||||
| Accretion Expense | $72k | — | — | — | — | — | — | — | — | — | — | |
| Deconsolidation, Gain (Loss), Amount | — | — | — | — | — | $13.6m | — | — | — | — | — | |
| Gain (Loss) on Disposition of Assets | — | — | — | ($1.0m) | ($240k) | ($348k) | ($141k) | ($475k) | ($9k) | ($39k) | — | |
| Gain (Loss) on Disposition of Intangible Assets | — | $2.6m | — | — | — | — | — | — | — | — | — | |
| General and Administrative Expense | $41.8m | $44.5m | $49.9m | $50.3m | $50.4m | $51.4m | $45.1m | $51.5m | $56.7m | $85.9m | — | |
| Goodwill | $4.0m | $4.5m | $4.0m | $3.6m | $3.9m | $3.3m | $3.1m | $3.2m | $3.0m | $3.4m | $0 | |
| Income Tax Expense (Benefit) | $4.4m | ($2.9m) | ($3.3m) | $13.7m | $3.5m | $20.6m | $23.5m | $31.8m | $29.7m | $25.5m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $30.3m | $25.5m | — | |
| Investment Income, Interest | $270k | $425k | $456k | $997k | $642k | $601k | $1.3m | $5.5m | $10.6m | $8.7m | — | |
| Operating Expenses | $88.5m | $91.7m | $115.6m | $132.0m | $132.4m | $129.9m | $141.4m | $154.1m | $168.4m | $215.7m | — | |
| Pension Cost (Reversal of Cost) | $200k | $200k | $300k | $200k | $200k | $200k | — | — | $0 | $0 | — |